Boyer Financial Services’s Cardiol Therapeutics CRDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.6K Hold
34,100
– – 0.05% 60
2026
Q2
$35.8K Buy
34,100
+11,000
+48% +$13.9K 0.03% 56
2026
Q1
$31.2K Sell
23,100
-10,000
-30% -$10.3K 0.03% 42
2025
Q4
$32.9K Buy
+33,100
New +$34.7K 0.03% 49

Other funds holding CRDL

Boyer Financial Services's CRDL Position: Q3 2026 in Review

Boyer Financial Services held its Cardiol Therapeutics (CRDL) position steady in Q3 2026 at 34,100 shares worth $56.6K. The position accounts for 0.05% of the portfolio, ranked #60.

Boyer Financial Services first reported a position in CRDL in Q4 2025 and has held it in 4 quarters since. 58 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.

  • Boyer Financial Services held 34,100 shares of Cardiol Therapeutics worth $56.6K as of Q3 2026.
  • Boyer Financial Services left its Cardiol Therapeutics share count unchanged in Q3 2026.
  • Cardiol Therapeutics made up 0.05% of Boyer Financial Services's portfolio in Q3 2026, its #60 holding.
  • Boyer Financial Services first reported a position in Cardiol Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 58 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.

Based on Boyer Financial Services's 13F filing for Q3 2026, filed 23 Oct 2026.